Alpha DNA Investment Management LLC Acquires 111 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Alpha DNA Investment Management LLC raised its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 3.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,411 shares of the healthcare conglomerate’s stock after purchasing an additional 111 shares during the quarter. Alpha DNA Investment Management LLC’s holdings in UnitedHealth Group were worth $1,725,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in UNH. NewSquare Capital LLC bought a new stake in shares of UnitedHealth Group during the fourth quarter valued at approximately $25,000. Hurley Capital LLC bought a new stake in UnitedHealth Group during the 4th quarter valued at $28,000. Aster Capital Management DIFC Ltd bought a new position in shares of UnitedHealth Group during the 4th quarter worth $30,000. AlphaMark Advisors LLC bought a new stake in shares of UnitedHealth Group in the fourth quarter valued at about $30,000. Finally, Promus Capital LLC purchased a new position in UnitedHealth Group during the 4th quarter valued at about $32,000. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Down 22.0 %

NYSE:UNH opened at $456.10 on Friday. UnitedHealth Group Incorporated has a 1-year low of $438.50 and a 1-year high of $630.73. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The firm has a market capitalization of $417.20 billion, a P/E ratio of 29.43, a PEG ratio of 1.37 and a beta of 0.61. The company’s fifty day moving average price is $514.51 and its 200-day moving average price is $541.53.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $109.58 billion during the quarter, compared to analysts’ expectations of $111.56 billion. During the same quarter in the previous year, the company earned $6.91 EPS. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were issued a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 1.84%. UnitedHealth Group’s payout ratio is 54.19%.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on UNH. Barclays cut their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a report on Friday, January 17th. KeyCorp restated an “overweight” rating and set a $650.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. Cantor Fitzgerald reissued an “overweight” rating and set a $700.00 price target on shares of UnitedHealth Group in a research report on Friday, January 17th. Mizuho boosted their price objective on shares of UnitedHealth Group from $600.00 to $650.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 9th. Finally, Piper Sandler cut their price target on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. Twenty-one investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Buy” and an average target price of $632.85.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.